GalaxiaMoneytree Terminates Debt Guarantee for Daegu Pharmaceutical Without Extension… Subrogation Risk Remains for Unsettled Balance of 2.69B KRW

Event: GalaxiaMoneytree disclosed a correction that its debt guarantee for Daegu Pharmaceutical (initially 8.4B KRW) will terminate on May 31, 2026 without extension
Reason: Termination of the business partnership (guarantee agreement) leads to expiration of the guarantee period
Risk: Due to timing differences in credit card settlements, an unpaid balance of 2.692B KRW remains to the creditor (Shinhan Card). If Daegu Pharmaceutical fails to pay, GalaxiaMoneytree may incur subrogation obligations
Figures: The remaining guarantee balance of 2.692B KRW represents 2.4% of equity (approx. 112.1B KRW), limiting direct financial impact. However, Daegu Pharmaceutical's weak financials (debt ratio 3,218%, equity capital 0.66B KRW) pose credit risk
[AI Comprehensive Analysis]This disclosure presents mixed signals: positive due to guarantee termination, but negative due to contingent liability from unsettled balance. Daegu Pharmaceutical's payment performance will be a key factor for stock price outlook and investment risk. While short-term impact is limited, deterioration of the debtor's financial health could trigger subrogation costs.